Your Patients Can't Find Bronkaid Max — Here's How You Can Help

Patients who use Bronkaid Max (Ephedrine Sulfate 25 mg) for mild intermittent asthma are increasingly coming to your office frustrated. They've tried multiple pharmacies, been told the product is out of stock, and are looking for guidance. As a provider, you're in a unique position to help them navigate this challenge.

This guide covers the current availability situation, why patients are struggling, and specific steps you can take to help — including tools, workflow tips, and alternative options.

Current Availability of Bronkaid Max

As of 2026, Bronkaid Max is not in a formal drug shortage. Foundation Consumer Healthcare continues to manufacture it, and it's available through standard wholesale distribution. The product is not listed on FDA, ASHP, or Drugs.com shortage databases.

However, pharmacy-level availability is inconsistent:

• Not all pharmacy locations stock it
• Some chains have sporadic availability
• State-level regulations create additional barriers in certain markets

The core issue is accessibility, not supply. Patients often can't find it — not because it isn't made, but because the regulatory environment makes it harder for pharmacies to stock and sell.

Why Patients Can't Find Bronkaid Max

Understanding the barriers helps you counsel patients effectively:

Behind-the-Counter Regulations

Under the Combat Methamphetamine Epidemic Act (CMEA), Bronkaid Max must be stored behind the pharmacy counter. Every sale requires photo ID verification, a signed logbook, and adherence to quantity limits (3.6g/day, 9g/30 days). This regulatory overhead leads some pharmacies to simply not carry the product.

Formula Transition Aftermath

The 2020 switch from the original Bronkaid (Ephedrine Sulfate + Guaifenesin) to Bronkaid Max (Ephedrine Sulfate only) caused distribution gaps. Some pharmacies that delisted the old product never onboarded the new formula.

Low Priority for Pharmacy Inventory

With a relatively small customer base, Bronkaid Max often falls to the bottom of pharmacy reorder priorities. When a location sells out, restocking may take weeks — or may not happen at all without customer demand.

State Variability

A few states have imposed prescription requirements or stricter purchase limits for ephedrine products, further restricting patient access.

What Providers Can Do: 5 Practical Steps

Step 1: Include Bronkaid Max in Medication Reconciliation

Because Bronkaid Max is OTC, it may not appear in pharmacy records or medication lists. Proactively ask patients about OTC asthma medications during visits. Many patients don't think to mention them. Knowing a patient uses ephedrine is clinically important given its cardiovascular profile and interaction potential (especially with MAOIs, antidepressants, and other sympathomimetics).

Step 2: Direct Patients to Medfinder

Medfinder for Providers is a free tool that helps patients search for medication availability at nearby pharmacies. You can:

• Share the link during the visit
• Have your front desk include it in patient handouts
• Use it during the appointment to identify a pharmacy with stock

This is significantly more effective than telling patients to "call around" — it saves them time and frustration.

Step 3: Help Patients Work with Their Pharmacist

Educate patients on how to work with their pharmacy to ensure consistent access:

• Ask for a special order: Most pharmacies can order Bronkaid Max through their wholesaler in 1-3 business days
• Request a standing order: If the patient uses it regularly, the pharmacist may be willing to keep it in stock
• Try multiple chains: CVS, Walgreens, Walmart, Kroger, and independents all have different stocking patterns
• Call ahead: Always verify stock before making the trip

Step 4: Evaluate Whether Prescription Therapy Is Appropriate

For many patients using Bronkaid Max, a prescription rescue inhaler may be both more effective and easier to obtain. Consider transitioning patients who:

• Use Bronkaid Max more than 4 times/day on 3+ days/week
• Have cardiovascular comorbidities (hypertension, heart disease, arrhythmias)
• Take interacting medications (MAOIs, TCAs, SSRIs, beta-blockers)
• Report worsening symptoms or inadequate relief
• Are unable to consistently find Bronkaid Max

Albuterol inhalers are the guideline-recommended rescue medication, work faster than oral ephedrine, and have a more favorable side effect profile. Generic Albuterol inhalers are available for $25-$50 cash price.

Step 5: Document the Access Challenge

When patients report difficulty finding Bronkaid Max, document it. This serves multiple purposes:

• Justifies clinical decision-making if transitioning to prescription therapy
• Supports prior authorization if needed for alternative medications
• Creates a record that may help identify patterns in your patient population

Alternative Medications to Consider

When Bronkaid Max isn't available or isn't the best fit, here are the alternatives:

OTC Options

• Primatene Tablets: Ephedrine HCl 12.5 mg + Guaifenesin 200 mg. Lower ephedrine dose with an added expectorant. Same behind-the-counter restrictions. ~$8-$15.
• Primatene Mist: Inhaled epinephrine 0.125 mg/spray. Faster onset than oral ephedrine. ~$27-$42.

Prescription Options

• Albuterol inhalers (ProAir, Ventolin, Proventil): Guideline-recommended SABA rescue therapy. Fast onset, more selective beta-2 agonism, fewer systemic side effects. Generic available at $25-$50 cash.
• Levalbuterol (Xopenex): R-isomer of Albuterol. Potentially fewer side effects. Available as inhaler and nebulizer solution.

For more detail, see our alternatives to Bronkaid Max guide and the shortage briefing for providers.

Workflow Tips for Your Practice

Here are ways to integrate Bronkaid Max access support into your clinical workflow:

• Add an OTC medication question to intake forms: "Do you use any over-the-counter medications for asthma, breathing, or allergies?"
• Create a patient handout: Include Medfinder, pharmacy calling tips, and a list of alternatives. Keep copies at the front desk.
• Flag patients using OTC ephedrine in their chart: This ensures it shows up in medication reconciliation and interaction checks.
• Set up a referral pathway: For patients who should transition from Bronkaid Max to prescription therapy, have a standard workflow (evaluation, prescription, pharmacy coordination).

Final Thoughts

Bronkaid Max isn't in shortage, but it's not easy for patients to find. As a provider, you can make a meaningful difference by directing patients to the right tools, helping them work with pharmacists, and knowing when to transition them to more effective prescription options.

Start by sharing Medfinder for Providers with your team. It's a simple step that can save your patients significant time and frustration.

For additional resources, see our guide to helping patients save money on Bronkaid Max.